ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.480
-0.185 (-11.11%)
Jul 11, 2025, 1:50 PM - Market open
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $67.73 million as of July 11, 2025. Its market cap has increased by 159.51% in one year.
Market Cap
67.73M
Enterprise Value
76.21M
1-Year Change
159.51%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $67.73M, a decrease of -72.97%. That is a compound annual growth rate of -25.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 54.70M | 388.39% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 701.36B |
| Johnson & Johnson | 373.78B |
| AbbVie | 336.57B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 277.16B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.39B |
| AstraZeneca | 216.19B |